Micrus Endovascular receives FDA clearance for Courier microcatheter

By Elaine Rigoli

Tampa, Fla., May 16 - Micrus Endovascular Corp. said it has received Food and Drug Administration clearance to market its Courier microcatheter line in the United States.

This product line is marketed in the European Union, having received CE Mark clearance in March.

Micrus said it intends to begin selling this product in the United States through its domestic direct sales force immediately.

Micrus Endovascular develops, manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases with offices located in San Jose, Calif., Switzerland and the United Kingdom.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.